The clinical significance and biological function of lncRNA RGMB-AS1 in hepatocellular carcinoma - 04/02/18
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 8 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
LncRNA RGMB-AS1 has been suggested to play significant roles in lung cancer progression. However, it remains unknown whether lncRNA RGMB-AS1 is involved in the development and progression of hepatocellular carcinoma. In our results, lncRNA RGMB-AS1 was low-expressed in hepatocellular carcinoma tissues and cell lines, and associated with clinical stage, tumor size and metastasis. Survival analysis indicated that lncRNA RGMB-AS1 high was an independent favorable prognostic factor for hepatocellular carcinoma patients. Gain-of-function studies showed up-regulated lncRNA RGMB-AS1 expression suppressed hepatocellular carcinoma cells proliferation, migration and invasion, and promoted cells apoptosis. There was a positively association between lncRNA RGMB-AS1 and RGMB in hepatocellular carcinoma tissues, and up-regulated lncRNA RGMB-AS1 expression increased RGMB mRNA and protein expressions in hepatocellular carcinoma cells. In conclusion, lncRNA RGMB-AS1 serves an anti-oncogenic role in hepatocellular carcinoma.
Le texte complet de cet article est disponible en PDF.Keywords : lncRNAs, RGMB, RGMB-AS1, Hepatocellular carcinoma, Biomarker
Plan
Vol 98
P. 577-584 - février 2018 Retour au numéro
Article précédent
- Effects of safflower yellow on beta-amyloid deposition and activation of astrocytes in the brain of APP/PS1 transgenic mice
- Xiao-meng Shi, Hua Zhang, Zhang-jiuzhi Zhou, Ying-ying Ruan, Jie Pang, Lu Zhang, Wei Zhai, Yan-li Hu
- Jobelyn® attenuates inflammatory responses and neurobehavioural deficits associated with complete Freund-adjuvant-induced arthritis in mice
- Osarume Omorogbe, Abayomi M. Ajayi, Benneth Ben-Azu, Ejiroghene E. Oghwere, Adaeze Adebesin, Adegbuyi O. Aderibigbe, Olajuwon Okubena, Solomon Umukoro
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?